Bioxyne eclipses revenue guidance with German deal set to 'underpin growth into FY26'
Summary by Cannabiz
1 Articles
1 Articles
Bioxyne eclipses revenue guidance with German deal set to 'underpin growth into FY26'
Alternative medicine manufacturer Bioxyne generated unaudited revenue of A$29.3 million in FY25, exceeding guidance by $1.3m. […] The post Bioxyne eclipses revenue guidance with German deal set to ‘underpin growth into FY26’ appeared first on Cannabiz.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium